Killing Cancer: Meet This Innovative Biotech Player

Killing Cancer: Meet This Innovative Biotech Player

Sign up for this week’s All Access giveaway here

Marc Hedrick MD, President and CEO of Plus Therapeutics, Inc PSTV, was a guest on Benzinga’s All Access on October 14, 2022.

Plus Therapeutics is developing targeted radiotherapeutics, a novel treatment for cancer. The technology delivers massive amounts of radiation to the tumor, without damaging the healthy cells surrounding the cancer.

Watch the full interview here:

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Posted In: Benzinga All AccessPartner ContentPlus TherapeuticsBiotechPenny StocksInterviewGeneral